blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3765486

EP3765486 - REAGENTS AND METHODS WITH WNT AGONISTS AND BIOACTIVE LIPIDS FOR GENERATING AND EXPANDING CARDIOMYOCYTES [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  29.08.2024
Database last updated on 19.10.2024
FormerRequest for examination was made
Status updated on  18.12.2020
FormerThe international publication has been made
Status updated on  21.09.2019
Most recent event   Tooltip30.08.2024First examination report 
Applicant(s)For all designated states
The Board of Trustees of the Leland Stanford Junior University
Office of the General Counsel
Building 170, Third Floor, Main Quad
P.O. Box 20386
Stanford, CA 94305-2038 / US
[2021/03]
Inventor(s)01 / WU, Sean M.
3000 El Camino Real Building Five,
Suite 300
Palo Alto, California 94306 / US
02 / BUIKEMA, Jan W.
3000 El Camino Real Building Five,
Suite 300
Palo Alto, California 94306 / US
03 / SHARMA, Arun
3000 El Camino Real Building Five,
Suite 300
Palo Alto, California 94306 / US
 [2021/03]
Representative(s)Marks & Clerk LLP
15 Fetter Lane
London EC4A 1BW / GB
[N/P]
Former [2021/03]Williams, Andrea
Marks & Clerk LLP
62-68 Hills Road
Cambridge CB2 1LA / GB
Application number, filing date19767843.615.03.2019
[2021/03]
WO2019US22469
Priority number, dateUS201862644091P16.03.2018         Original published format: US 201862644091 P
[2021/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019178478
Date:19.09.2019
Language:EN
[2019/38]
Type: A1 Application with search report 
No.:EP3765486
Date:20.01.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 19.09.2019 takes the place of the publication of the European patent application.
[2021/03]
Search report(s)International search report - published on:US19.09.2019
(Supplementary) European search report - dispatched on:EP28.01.2022
ClassificationIPC:C07K14/475, C12N5/07
[2021/03]
CPC:
C12N5/0657 (EP,US); A61K35/28 (EP); A61K35/34 (EP,US);
A61K35/545 (EP); C12N2500/36 (EP); C12N2501/415 (EP,US);
C12N2501/727 (US); C12N2503/02 (US); C12N2506/45 (EP,US);
Y02A50/30 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/03]
TitleGerman:REAGENZIEN UND VERFAHREN MIT WNT-AGONISTEN UND BIOAKTIVEN LIPIDEN ZUR ERZEUGUNG UND EXPANSION VON KARDIOMYOZYTEN[2021/03]
English:REAGENTS AND METHODS WITH WNT AGONISTS AND BIOACTIVE LIPIDS FOR GENERATING AND EXPANDING CARDIOMYOCYTES[2021/03]
French:RÉACTIFS ET PROCÉDÉS AVEC DES AGONISTES WNT ET DES LIPIDES BIOACTIFS POUR GÉNÉRER ET DÉVELOPPER DES CARDIOMYOCYTES[2021/03]
Entry into regional phase30.09.2020National basic fee paid 
30.09.2020Search fee paid 
30.09.2020Designation fee(s) paid 
30.09.2020Examination fee paid 
Examination procedure30.09.2020Examination requested  [2021/03]
10.08.2022Amendment by applicant (claims and/or description)
28.08.2024Despatch of a communication from the examining division (Time limit: M04)
Fees paidRenewal fee
30.09.2020Renewal fee patent year 03
23.03.2022Renewal fee patent year 04
22.03.2023Renewal fee patent year 05
23.03.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US2005261189  (LARSEN GLENN [US], et al) [X] 27 * entire document *;
 [A]US2008044848  (HEIDARAN MOHAMMAD A [US]) [A] 1-5, 12-15, 21-23, 27* entire document *;
 [Y]US2014134733  (WU JOSEPH [US], et al) [Y] 12-15, 21-23 * entire document *;
 [XY]US9074188  (YAMASHITA JUN [JP], et al) [X] 1-5 * entire document * [Y] 21-23;
 [Y]  - ZHAO et al., "Sphingosine-1-phosphate promotes the differentiation of human umbilical cord mesenchymal stem cells into cardiomyocytes under the designated culturing conditions", Journal of Biomedical Science, (20110607), vol. 18, no. 37, pages 1 - 9, XP021102481 [Y] 12-15 * . entire document *

DOI:   http://dx.doi.org/10.1186/1423-0127-18-37
 [Y]  - WENDLER et al., "Sphingosine-1-phosphate inhibits cell migration and endothelial to mesenchymal cell transformation during cardiac development", Developmental Biology, (20060315), vol. 291, no. 2, doi:doi:10.1016/j.ydbio.2005.12.013, pages 264 - 277, XP024943778 [Y] 21-23 * . entire document *

DOI:   http://dx.doi.org/10.1016/j.ydbio.2005.12.013
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.